The Tomaralimab Biosimilar TLR2 Antibody is a cutting-edge product designed for researchers studying Toll-like receptor 2 (TLR2) signaling pathways in the immune system. This antibody, produced using advanced biosimilar technology, effectively targets TLR2, a key receptor involved in the recognition of pathogen-associated molecular patterns.With its high specificity and sensitivity, the Tomaralimab Biosimilar TLR2 Antibody is an invaluable tool for investigating TLR2-mediated immune responses in various cell types and tissue samples. Its application in techniques such as Western blotting and immunohistochemistry enables precise detection and analysis of TLR2 expression and activity, facilitating a deeper understanding of immune system function and dysregulation.
TLR2 signaling plays a crucial role in the immune response to infections, inflammation, and autoimmune diseases, making the Tomaralimab Biosimilar Anti-TLR2 Antibody an essential resource for researchers exploring the immunological mechanisms underlying these conditions. By elucidating the complex interactions between TLR2 and its ligands, this antibody supports the development of novel therapeutic strategies targeting TLR2-mediated pathways for the treatment of infectious and inflammatory diseases.
Product Name:
Tomaralimab Biosimilar (TLR2) Antibody (HDBS0140)
Size:
100 ug
Product SKU:
HDBS0140
Target:
TLR2
Host Species:
Chimeric
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
OPN-305
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
system_update_altDatasheetBCMA Biosimilar Antibody (HDBS0016)The Anti-BCMA Monoclonal Antibody (HDbs0016) is a cutting-edge tool developed for researchers working in the f
system_update_altDatasheetMagrolimab Biosimilar, Igg1 Biosimilar (CD47) Antibody (HDBS0049)The CD47 Magroli Biosimilar (HDBS0049) is a cutting-edge product developed by As
system_update_altDatasheetShionogi CCR8 Biosimilar Antibody (HDBS0061)The Anti-CCR8 Antibody (HDBS0061) is a highly specific tool for researchers studying the CCR8 protein